Ignite Creation Date:
2025-12-24 @ 7:36 PM
Ignite Modification Date:
2026-02-23 @ 9:16 PM
Study NCT ID:
NCT02596503
Status:
COMPLETED
Last Update Posted:
2022-02-15
First Post:
2015-10-19
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of Eribulin in Combination With Oral Irinotecan for Adolescent and Young Adult Patients With Relapsed or Refractory Solid Tumors
Sponsor:
University of Colorado, Denver
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-10-21
Start Date Type:
ACTUAL
Primary Completion Date:
2019-04
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-01-24
Completion Date Type:
ACTUAL
First Submit Date:
2015-10-19
First Submit QC Date:
None
Study First Post Date:
2015-11-04
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-01-31
Last Update Post Date:
2022-02-15
Last Update Post Date Type:
ACTUAL